Press Releases :: VolitionRx Ltd (VNRX)

Jan 20, 2022 • 8:30 AM EST Volition presents study data at ASCO GI 2022 on circulating nucleosomes for the detection of colorectal cancer and high-risk advanced adenomas

Dec 16, 2021 • 8:00 AM EST Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Cancer Screening Test in Asia

Nov 10, 2021 • 4:10 PM EST VolitionRx Limited Announces Third Quarter 2021 Financial Results and Business Update

Nov 8, 2021 • 8:30 AM EST VolitionRx Limited Schedules Third Quarter 2021 Earnings Conference Call and Business Update

Nov 4, 2021 • 8:33 AM EDT Volition Veterinary Presents Two Posters at the 2021 Veterinary Cancer Society Conference

Aug 11, 2021 • 4:10 PM EDT VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business Update

Aug 4, 2021 • 8:15 AM EDT VolitionRx Limited Schedules Second Quarter 2021 Earnings Conference Call and Business Update

Jul 22, 2021 • 8:00 AM EDT Volition's Nu.Q® NETs Assay Demonstrates Promising Results in COVID-19 Risk Stratification and Disease Monitoring

May 11, 2021 • 4:10 PM EDT VolitionRx Limited Announces First Quarter 2021 Financial Results and Business Update

May 6, 2021 • 8:15 AM EDT VolitionRx Limited Schedules First Quarter 2021 Earnings Conference Call and Business Update

1
2
3
4
5
6
7
8
9
10
...28
Next »